Status:
COMPLETED
Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and Adult
Lead Sponsor:
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborating Sponsors:
Northwestern University Feinberg School of Medicine
Conditions:
Dermatitis, Seborrheic
Dry Skin; Eczema
Eligibility:
All Genders
1+ years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of a novel topical treatment for dry scalp conditions, including dandruff, seborrheic dermatitis, and atopic dermatitis. The study inve...
Detailed Description
This study evaluates the safety and efficacy of a novel topical scalp treatment for dry scalp conditions, including dandruff, seborrheic dermatitis, and atopic dermatitis. The treatment contains Lacto...
Eligibility Criteria
Inclusion
- Age 1 year (or corrected age of 1 year, for those born prematurely) to 17 years for children, and adults 18 and older
- Patients with dry scalp and dandruff symptoms as determined by a board-certified Dermatologist, Allergist, or Pediatrician
- Good general health
- Participant and/or their parents are able to read, write, and understand study materials in English
Exclusion
- Infants younger than 1 year old
- Patients diagnosed with other scalp diseases such as psoriasis, tinea capitis, and pediculosis capitis
- Systemic steroid or oral antibiotic use during the past two months
- Allergy to any of the preparation components
Key Trial Info
Start Date :
July 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 4 2023
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT03830177
Start Date
July 8 2019
End Date
October 4 2023
Last Update
February 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Dermatology Associates of Chicago
Chicago, Illinois, United States, 60654